MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,747 | -83.0% | 8,130 | -82.0% | 0.00% | – |
| Q4 2022 | $33,806 | -36.2% | 45,074 | -27.2% | 0.00% | – |
| Q3 2022 | $53,000 | -1.9% | 61,888 | +28.1% | 0.00% | – |
| Q2 2022 | $54,000 | +157.1% | 48,301 | +158.4% | 0.00% | – |
| Q1 2022 | $21,000 | -27.6% | 18,694 | +2.2% | 0.00% | – |
| Q4 2021 | $29,000 | +222.2% | 18,294 | +378.1% | 0.00% | – |
| Q3 2021 | $9,000 | -75.0% | 3,826 | -66.5% | 0.00% | – |
| Q2 2021 | $36,000 | – | 11,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,854,278 | $6,638,000 | 3.61% |
| Asymmetry Capital Management, L.P. | 739,812 | $2,649,000 | 1.21% |
| Affinity Asset Advisors, LLC | 625,000 | $2,238,000 | 1.19% |
| Tri Locum Partners LP | 728,710 | $2,609,000 | 0.95% |
| Boxer Capital, LLC | 6,226,673 | $22,291,000 | 0.72% |
| DAFNA Capital Management LLC | 668,148 | $2,392,000 | 0.71% |
| Vivo Capital, LLC | 4,220,938 | $15,111,000 | 0.67% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $919,000 | 0.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 280,000 | $1,002,000 | 0.58% |
| Rubric Capital Management LP | 1,853,417 | $6,635,000 | 0.49% |